カテゴリ： LP Information, 世界, 医療/バイオ

低侵襲的女性用尿失禁装置のグローバル市場予測2023-2029

■ 英語タイトル：Global Minimally Invasive Female Urinary Incontinence Devices Market Growth 2023-2029

調査会社LP Information社が発行したリサーチレポート（データ管理コード：LP23JU1353）■ 発行会社/調査会社：LP Information
■ 商品コード：LP23JU1353
■ 発行日：2023年5月
■ 調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
■ 産業分野：医療装置＆消耗品
■ ページ数：113
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※LP Information社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[低侵襲的女性用尿失禁装置のグローバル市場予測2023-2029]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

LP Informationの最新刊調査レポート「低侵襲的女性用尿失禁装置のグローバル市場」は、過去の販売実績から2022年の世界の低侵襲的女性用尿失禁装置の総販売量を検討し、2023年から2029年の予測される低侵襲的女性用尿失禁装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の低侵襲的女性用尿失禁装置の市場規模を掲載し、XXX百万米ドル規模の世界の低侵襲的女性用尿失禁装置市場の詳細な分析を提供します。本インサイトレポートは、世界の低侵襲的女性用尿失禁装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の低侵襲的女性用尿失禁装置市場における各社の独自のポジションをより深く理解するために、低侵襲的女性用尿失禁装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の低侵襲的女性用尿失禁装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。低侵襲的女性用尿失禁装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。低侵襲的女性用尿失禁装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。低侵襲的女性用尿失禁装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

低侵襲的女性用尿失禁装置の世界主要メーカーとしては、Axonics Modulation Technologies, Inc、 Bioness, Inc.、 BlueWind Medical Ltd.、 Boston Scientific Corporation、 Caldera Medical, Inc.、 Carbon Medical Technologies, Inc.、 CL Medical、 Cogentix Medical, Coloplast Corporation, Cousin Biotech、 C. R. Bard, Inc. (Becton, Dickinson and Company)、 Ethicon, Inc./Johnson & Johnson、 FemPulse, LLC、 InterStim, Medtronic, Inc.、 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA、 NURO Sys、 Nuvectra Corporation、 StimGuard LLC.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の低侵襲的女性用尿失禁装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では低侵襲的女性用尿失禁装置市場をセグメンテーションし、種類別 (体外式尿失禁装置、体内式尿失禁装置)、用途別 (外来手術センター、婦人科医院、病院)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：体外式尿失禁装置、体内式尿失禁装置

・用途別区分：外来手術センター、婦人科医院、病院

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の低侵襲的女性用尿失禁装置市場の10年間の市場状況・展望は？
・世界および地域別に見た低侵襲的女性用尿失禁装置市場成長の要因は何か？
・低侵襲的女性用尿失禁装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・低侵襲的女性用尿失禁装置のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：低侵襲的女性用尿失禁装置の年間販売量2018-2029、地域別現状・将来分析
・低侵襲的女性用尿失禁装置の種類別セグメント：体外式尿失禁装置、体内式尿失禁装置
・低侵襲的女性用尿失禁装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・低侵襲的女性用尿失禁装置の用途別セグメント：外来手術センター、婦人科医院、病院
・低侵襲的女性用尿失禁装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の低侵襲的女性用尿失禁装置市場
・企業別のグローバル低侵襲的女性用尿失禁装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の低侵襲的女性用尿失禁装置の年間売上：2018-2023年の売上、市場シェア
・企業別の低侵襲的女性用尿失禁装置販売価格
・主要企業の低侵襲的女性用尿失禁装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

低侵襲的女性用尿失禁装置の地域別レビュー
・地域別の低侵襲的女性用尿失禁装置市場規模2018-2023：年間販売量、売上
・主要国別の低侵襲的女性用尿失禁装置市場規模2018-2023：年間販売量、売上
・南北アメリカの低侵襲的女性用尿失禁装置販売の成長
・アジア太平洋の低侵襲的女性用尿失禁装置販売の成長
・ヨーロッパの低侵襲的女性用尿失禁装置販売の成長
・中東・アフリカの低侵襲的女性用尿失禁装置販売の成長

南北アメリカ市場
・南北アメリカの国別の低侵襲的女性用尿失禁装置販売量、売上（2018-2023）
・南北アメリカの低侵襲的女性用尿失禁装置の種類別販売量
・南北アメリカの低侵襲的女性用尿失禁装置の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の低侵襲的女性用尿失禁装置販売量、売上（2018-2023）
・アジア太平洋の低侵襲的女性用尿失禁装置の種類別販売量
・アジア太平洋の低侵襲的女性用尿失禁装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の低侵襲的女性用尿失禁装置販売量、売上（2018-2023）
・ヨーロッパの低侵襲的女性用尿失禁装置の種類別販売量
・ヨーロッパの低侵襲的女性用尿失禁装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の低侵襲的女性用尿失禁装置販売量、売上（2018-2023）
・中東・アフリカの低侵襲的女性用尿失禁装置の種類別販売量
・中東・アフリカの低侵襲的女性用尿失禁装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・低侵襲的女性用尿失禁装置の製造コスト構造分析
・低侵襲的女性用尿失禁装置の製造プロセス分析
・低侵襲的女性用尿失禁装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・低侵襲的女性用尿失禁装置の主要なグローバル販売業者
・低侵襲的女性用尿失禁装置の主要なグローバル顧客

地域別の低侵襲的女性用尿失禁装置市場予測レビュー
・地域別の低侵襲的女性用尿失禁装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・低侵襲的女性用尿失禁装置の種類別市場規模予測
・低侵襲的女性用尿失禁装置の用途別市場規模予測

主要企業分析
Axonics Modulation Technologies, Inc、 Bioness, Inc.、 BlueWind Medical Ltd.、 Boston Scientific Corporation、 Caldera Medical, Inc.、 Carbon Medical Technologies, Inc.、 CL Medical、 Cogentix Medical, Coloplast Corporation, Cousin Biotech、 C. R. Bard, Inc. (Becton, Dickinson and Company)、 Ethicon, Inc./Johnson & Johnson、 FemPulse, LLC、 InterStim, Medtronic, Inc.、 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA、 NURO Sys、 Nuvectra Corporation、 StimGuard LLC.
・企業情報
・低侵襲的女性用尿失禁装置製品
・低侵襲的女性用尿失禁装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Minimally Invasive Female Urinary Incontinence Devices Industry Forecast” looks at past sales and reviews total world Minimally Invasive Female Urinary Incontinence Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Minimally Invasive Female Urinary Incontinence Devices sales for 2023 through 2029. With Minimally Invasive Female Urinary Incontinence Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Minimally Invasive Female Urinary Incontinence Devices industry.
This Insight Report provides a comprehensive analysis of the global Minimally Invasive Female Urinary Incontinence Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Minimally Invasive Female Urinary Incontinence Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Minimally Invasive Female Urinary Incontinence Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Minimally Invasive Female Urinary Incontinence Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Minimally Invasive Female Urinary Incontinence Devices.
The global Minimally Invasive Female Urinary Incontinence Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Minimally Invasive Female Urinary Incontinence Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Minimally Invasive Female Urinary Incontinence Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Minimally Invasive Female Urinary Incontinence Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Minimally Invasive Female Urinary Incontinence Devices players cover Axonics Modulation Technologies, Inc, Bioness, Inc., BlueWind Medical Ltd., Boston Scientific Corporation, Caldera Medical, Inc., Carbon Medical Technologies, Inc., CL Medical, Cogentix Medical, Coloplast Corporation, Cousin Biotech and C. R. Bard, Inc. (Becton, Dickinson and Company), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Minimally Invasive Female Urinary Incontinence Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
External Urinary Incontinence Devices
Internal Urinary Incontinence Devices
Segmentation by application
Ambulatory Surgical Centers
Gynecology Clinics
Hospitals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Axonics Modulation Technologies, Inc
Bioness, Inc.
BlueWind Medical Ltd.
Boston Scientific Corporation
Caldera Medical, Inc.
Carbon Medical Technologies, Inc.
CL Medical
Cogentix Medical, Coloplast Corporation, Cousin Biotech
C. R. Bard, Inc. (Becton, Dickinson and Company)
Ethicon, Inc./Johnson & Johnson
FemPulse, LLC
InterStim, Medtronic, Inc.
Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA
NURO Sys
Nuvectra Corporation
StimGuard LLC.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Minimally Invasive Female Urinary Incontinence Devices market?
What factors are driving Minimally Invasive Female Urinary Incontinence Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Minimally Invasive Female Urinary Incontinence Devices market opportunities vary by end market size?
How does Minimally Invasive Female Urinary Incontinence Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Minimally Invasive Female Urinary Incontinence Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Minimally Invasive Female Urinary Incontinence Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Minimally Invasive Female Urinary Incontinence Devices by Country/Region, 2018, 2022 & 2029
2.2 Minimally Invasive Female Urinary Incontinence Devices Segment by Type
2.2.1 External Urinary Incontinence Devices
2.2.2 Internal Urinary Incontinence Devices
2.3 Minimally Invasive Female Urinary Incontinence Devices Sales by Type
2.3.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Minimally Invasive Female Urinary Incontinence Devices Sale Price by Type (2018-2023)
2.4 Minimally Invasive Female Urinary Incontinence Devices Segment by Application
2.4.1 Ambulatory Surgical Centers
2.4.2 Gynecology Clinics
2.4.3 Hospitals
2.5 Minimally Invasive Female Urinary Incontinence Devices Sales by Application
2.5.1 Global Minimally Invasive Female Urinary Incontinence Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Minimally Invasive Female Urinary Incontinence Devices Sale Price by Application (2018-2023)
3 Global Minimally Invasive Female Urinary Incontinence Devices by Company
3.1 Global Minimally Invasive Female Urinary Incontinence Devices Breakdown Data by Company
3.1.1 Global Minimally Invasive Female Urinary Incontinence Devices Annual Sales by Company (2018-2023)
3.1.2 Global Minimally Invasive Female Urinary Incontinence Devices Sales Market Share by Company (2018-2023)
3.2 Global Minimally Invasive Female Urinary Incontinence Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Minimally Invasive Female Urinary Incontinence Devices Revenue by Company (2018-2023)
3.2.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue Market Share by Company (2018-2023)
3.3 Global Minimally Invasive Female Urinary Incontinence Devices Sale Price by Company
3.4 Key Manufacturers Minimally Invasive Female Urinary Incontinence Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Minimally Invasive Female Urinary Incontinence Devices Product Location Distribution
3.4.2 Players Minimally Invasive Female Urinary Incontinence Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Minimally Invasive Female Urinary Incontinence Devices by Geographic Region
4.1 World Historic Minimally Invasive Female Urinary Incontinence Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Minimally Invasive Female Urinary Incontinence Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Minimally Invasive Female Urinary Incontinence Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Minimally Invasive Female Urinary Incontinence Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Minimally Invasive Female Urinary Incontinence Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Minimally Invasive Female Urinary Incontinence Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Minimally Invasive Female Urinary Incontinence Devices Sales Growth
4.4 APAC Minimally Invasive Female Urinary Incontinence Devices Sales Growth
4.5 Europe Minimally Invasive Female Urinary Incontinence Devices Sales Growth
4.6 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Sales Growth
5 Americas
5.1 Americas Minimally Invasive Female Urinary Incontinence Devices Sales by Country
5.1.1 Americas Minimally Invasive Female Urinary Incontinence Devices Sales by Country (2018-2023)
5.1.2 Americas Minimally Invasive Female Urinary Incontinence Devices Revenue by Country (2018-2023)
5.2 Americas Minimally Invasive Female Urinary Incontinence Devices Sales by Type
5.3 Americas Minimally Invasive Female Urinary Incontinence Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Minimally Invasive Female Urinary Incontinence Devices Sales by Region
6.1.1 APAC Minimally Invasive Female Urinary Incontinence Devices Sales by Region (2018-2023)
6.1.2 APAC Minimally Invasive Female Urinary Incontinence Devices Revenue by Region (2018-2023)
6.2 APAC Minimally Invasive Female Urinary Incontinence Devices Sales by Type
6.3 APAC Minimally Invasive Female Urinary Incontinence Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Minimally Invasive Female Urinary Incontinence Devices by Country
7.1.1 Europe Minimally Invasive Female Urinary Incontinence Devices Sales by Country (2018-2023)
7.1.2 Europe Minimally Invasive Female Urinary Incontinence Devices Revenue by Country (2018-2023)
7.2 Europe Minimally Invasive Female Urinary Incontinence Devices Sales by Type
7.3 Europe Minimally Invasive Female Urinary Incontinence Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices by Country
8.1.1 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Sales by Type
8.3 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Minimally Invasive Female Urinary Incontinence Devices
10.3 Manufacturing Process Analysis of Minimally Invasive Female Urinary Incontinence Devices
10.4 Industry Chain Structure of Minimally Invasive Female Urinary Incontinence Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Minimally Invasive Female Urinary Incontinence Devices Distributors
11.3 Minimally Invasive Female Urinary Incontinence Devices Customer
12 World Forecast Review for Minimally Invasive Female Urinary Incontinence Devices by Geographic Region
12.1 Global Minimally Invasive Female Urinary Incontinence Devices Market Size Forecast by Region
12.1.1 Global Minimally Invasive Female Urinary Incontinence Devices Forecast by Region (2024-2029)
12.1.2 Global Minimally Invasive Female Urinary Incontinence Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Minimally Invasive Female Urinary Incontinence Devices Forecast by Type
12.7 Global Minimally Invasive Female Urinary Incontinence Devices Forecast by Application
13 Key Players Analysis
13.1 Axonics Modulation Technologies, Inc
13.1.1 Axonics Modulation Technologies, Inc Company Information
13.1.2 Axonics Modulation Technologies, Inc Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.1.3 Axonics Modulation Technologies, Inc Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Axonics Modulation Technologies, Inc Main Business Overview
13.1.5 Axonics Modulation Technologies, Inc Latest Developments
13.2 Bioness, Inc.
13.2.1 Bioness, Inc. Company Information
13.2.2 Bioness, Inc. Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.2.3 Bioness, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bioness, Inc. Main Business Overview
13.2.5 Bioness, Inc. Latest Developments
13.3 BlueWind Medical Ltd.
13.3.1 BlueWind Medical Ltd. Company Information
13.3.2 BlueWind Medical Ltd. Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.3.3 BlueWind Medical Ltd. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BlueWind Medical Ltd. Main Business Overview
13.3.5 BlueWind Medical Ltd. Latest Developments
13.4 Boston Scientific Corporation
13.4.1 Boston Scientific Corporation Company Information
13.4.2 Boston Scientific Corporation Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.4.3 Boston Scientific Corporation Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boston Scientific Corporation Main Business Overview
13.4.5 Boston Scientific Corporation Latest Developments
13.5 Caldera Medical, Inc.
13.5.1 Caldera Medical, Inc. Company Information
13.5.2 Caldera Medical, Inc. Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.5.3 Caldera Medical, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Caldera Medical, Inc. Main Business Overview
13.5.5 Caldera Medical, Inc. Latest Developments
13.6 Carbon Medical Technologies, Inc.
13.6.1 Carbon Medical Technologies, Inc. Company Information
13.6.2 Carbon Medical Technologies, Inc. Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.6.3 Carbon Medical Technologies, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Carbon Medical Technologies, Inc. Main Business Overview
13.6.5 Carbon Medical Technologies, Inc. Latest Developments
13.7 CL Medical
13.7.1 CL Medical Company Information
13.7.2 CL Medical Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.7.3 CL Medical Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CL Medical Main Business Overview
13.7.5 CL Medical Latest Developments
13.8 Cogentix Medical, Coloplast Corporation, Cousin Biotech
13.8.1 Cogentix Medical, Coloplast Corporation, Cousin Biotech Company Information
13.8.2 Cogentix Medical, Coloplast Corporation, Cousin Biotech Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.8.3 Cogentix Medical, Coloplast Corporation, Cousin Biotech Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cogentix Medical, Coloplast Corporation, Cousin Biotech Main Business Overview
13.8.5 Cogentix Medical, Coloplast Corporation, Cousin Biotech Latest Developments
13.9 C. R. Bard, Inc. (Becton, Dickinson and Company)
13.9.1 C. R. Bard, Inc. (Becton, Dickinson and Company) Company Information
13.9.2 C. R. Bard, Inc. (Becton, Dickinson and Company) Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.9.3 C. R. Bard, Inc. (Becton, Dickinson and Company) Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 C. R. Bard, Inc. (Becton, Dickinson and Company) Main Business Overview
13.9.5 C. R. Bard, Inc. (Becton, Dickinson and Company) Latest Developments
13.10 Ethicon, Inc./Johnson & Johnson
13.10.1 Ethicon, Inc./Johnson & Johnson Company Information
13.10.2 Ethicon, Inc./Johnson & Johnson Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.10.3 Ethicon, Inc./Johnson & Johnson Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ethicon, Inc./Johnson & Johnson Main Business Overview
13.10.5 Ethicon, Inc./Johnson & Johnson Latest Developments
13.11 FemPulse, LLC
13.11.1 FemPulse, LLC Company Information
13.11.2 FemPulse, LLC Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.11.3 FemPulse, LLC Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 FemPulse, LLC Main Business Overview
13.11.5 FemPulse, LLC Latest Developments
13.12 InterStim, Medtronic, Inc.
13.12.1 InterStim, Medtronic, Inc. Company Information
13.12.2 InterStim, Medtronic, Inc. Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.12.3 InterStim, Medtronic, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 InterStim, Medtronic, Inc. Main Business Overview
13.12.5 InterStim, Medtronic, Inc. Latest Developments
13.13 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA
13.13.1 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Company Information
13.13.2 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.13.3 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Main Business Overview
13.13.5 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Latest Developments
13.14 NURO Sys
13.14.1 NURO Sys Company Information
13.14.2 NURO Sys Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.14.3 NURO Sys Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 NURO Sys Main Business Overview
13.14.5 NURO Sys Latest Developments
13.15 Nuvectra Corporation
13.15.1 Nuvectra Corporation Company Information
13.15.2 Nuvectra Corporation Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.15.3 Nuvectra Corporation Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Nuvectra Corporation Main Business Overview
13.15.5 Nuvectra Corporation Latest Developments
13.16 StimGuard LLC.
13.16.1 StimGuard LLC. Company Information
13.16.2 StimGuard LLC. Minimally Invasive Female Urinary Incontinence Devices Product Portfolios and Specifications
13.16.3 StimGuard LLC. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 StimGuard LLC. Main Business Overview
13.16.5 StimGuard LLC. Latest Developments
14 Research Findings and Conclusion



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 低侵襲的減量（肥満）用装置のグローバル市場予測2023-2029
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(LP23JU1353 )"低侵襲的女性用尿失禁装置のグローバル市場予測2023-2029" (英文：Global Minimally Invasive Female Urinary Incontinence Devices Market Growth 2023-2029)はLP Information社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。